In TME, IL‐6 and CCL2 trigger autophagy, respectively, by binding to interleukin 6 receptor (IL‐6R) and CC chemokine receptor 2 (CCR2) and induce macrophage towards M2 type, which is strong support for maintaining inhibitory TIME and promoting tumour progression.85, 86. This evidence concerns the gene IL6R and neoplasm.